Skip to content

A prospective study to study the effect of intra-operative lidocaine 2% infusion in reducing intra-operative and postoperative opioid requirements for analgesia in patients undergoing renal transplantation surgery

the role of Intraoperative lidocaine 2% infusion in reducing postoperative fentanyl requirements for pain control during renal transplantation surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001335280
Enrollment
50
Registered
2018-08-08
Start date
2018-04-23
Completion date
2018-12-26
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Intraoperative lidocaine 2% infusion reduces intraoperative and postoperative opioid requirements for analgesia. Fifty patients were enrolled, the control group (n = 25) received fentanyl 3 µg/kg and lidocaine group received fentanyl 1.5 µg/kg and loading dose of lidocaine 2% 1.5 mg/kg loading with maintenance dose of lidocaine 2% infusion 2 mg/k/hr .

Interventions

50 Patients were randomly scheduled into 2 groups: Fentanyl (F) group and lidocaine (L) group, 25 patients in each group. The anesthetic techniques were standardized patients were pre medicated by midazolam 0.03mg/kg IV. Induction of anesthesia started by Propofol 2.5mg/kg IV, Fentanyl 3 ug/kg for the fentanyl group and 1.5 ug/kg for the lidocaine group with lidocaine 2% 1.5 mg/kg as loading dose followed by the maintenance dose of lidocaine 2% 2mg/kg/hr. Lidocaine infusion stopped with the be

50 Patients were randomly scheduled into 2 groups: Fentanyl (F) group and lidocaine (L) group, 25 patients in each group. The anesthetic techniques were standardized patients were pre medicated by midazolam 0.03mg/kg IV. Induction of anesthesia started by Propofol 2.5mg/kg IV, Fentanyl 3 ug/kg for the fentanyl group and 1.5 ug/kg for the lidocaine group with lidocaine 2% 1.5 mg/kg as loading dose followed by the maintenance dose of lidocaine 2% 2mg/kg/hr. Lidocaine infusion stopped with the beginning of skin closure. The primary outcome variable was the amount of fentanyl required in the PACU to establish and to maintain visual analogue scale pain scores < 4.

Sponsors

king Faisal specialized hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver)

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

patients undergoing renal transplantation, age 16-70 years

Exclusion criteria

liver cell failure, heart failure, chronic use of opioids, and allergy to the used medications either lidocaine 2% or fentanyl and inability to comprehended pain

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 17, 2026